Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis (Q40964384)

25 September 2017

1 reference

title

Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis (English)

1 reference

25 September 2017

Schlievert PM

1 reference

25 September 2017

Assimacopoulos AP

series ordinal

1 reference

25 September 2017

Cleary PP

series ordinal

1 reference

25 September 2017

language of work or name

1 reference

1 January 1996

1 reference

25 September 2017

published in

Translational Research

1 reference

25 September 2017

volume

127

1 reference

25 September 2017

1 reference

25 September 2017

page(s)

13-22

1 reference

Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Toxic-shock syndrome associated with phage-group-I Staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Severe Invasive Group A Streptococcal Infections In Ontario, Canada: 1987-1991

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Group A Streptococcal Bacteremia in a Mid-South Childrenʼs Hospital

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Association of exotoxin-producing group A streptococci and severe disease in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Invasive group A streptococcus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Group B streptococcal toxic shock-like syndrome: report of a case and purification of an associated pyrogenic toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Role of superantigens in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Recent changes in group A streptococcal serotypes from uncomplicated pharyngitis: a reflection of the changing epidemiology of severe group A infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Clonal basis for resurgence of serious Streptococcus pyogenes disease in the 1980s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Changes in the pattern of infection caused by Streptococcus pyogenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Molecular epidemiology of group A streptococcus M type 1 infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Evaluation of methods for epidemiologic typing of group A streptococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Streptococcal serogroup A epidemic in Norway 1987-1988.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Treatment failures and carriers: perception or problems?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

The staphylococcal enterotoxins and their relatives.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Structure of toxic shock syndrome toxin 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Characterization of Staphylococcus aureus isolates from patients with toxic shock syndrome, using polyethylene infection chambers in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0022-2143%2896%2990161-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-2143(96)90161-4

1 reference

25 September 2017

1 reference